MK0782
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Stomach Ulcer
Conditions
Stomach Ulcer, Duodenal Ulcer
Trial Timeline
Jun 1, 2004 → Aug 1, 2004
NCT ID
NCT00543868About MK0782
MK0782 is a phase 2 stage product being developed by Merck for Stomach Ulcer. The current trial status is completed. This product is registered under clinical trial identifier NCT00543868. Target conditions include Stomach Ulcer, Duodenal Ulcer.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00543465 | Phase 2 | Terminated |
| NCT00543868 | Phase 2 | Completed |
Competing Products
20 competing products in Stomach Ulcer